Thomas Todorow

Vasca, Inc. develops access and related technologies. It manufactures and markets life site hemodialysis access system technologies to improve the quality of patient care in the United States. The company was founded by Jeffrey H. Burbank in April 1996 and is headquartered in Tewksbury, MA.

Direct Flow Medical, Inc. develops transcatheter heart valve technologies. It explores application of its technology beyond the aortic valve, to the mitral valve, and other valve anatomy. The firm’s Transcatheter Aortic Valve System is indicated for the treatment of patients with severe aortic stenosis, who are at risk for surgical aortic valve replacement. The company's system incorporates a polymer frame, which is expanded using pressurized saline and contrast for placement, assessment and repositioning. Direct Flow Medical was founded by Gordon B. Bishop and Randall T. Lashinski in June 2004 and is headquartered in Santa Rosa, CA.

AgResearch Ltd. engages in research and development activities in the pastoral sector. It offers NaturOTM analgesia system, CARLA Saliva Test, WormFEC and MicroManual products. Its services include bioinformatics, development engineering, farms and deoxyribonucleic acid testing laboratory. The company was founded in 1992 and is headquartered in Hamilton, New Zealand.

Siemens Medical Solutions USA, Inc. provides medical products and solutions. It offers imaging systems, therapy equipment, and hearing instruments for diagnosis, treatments, and patient monitoring. The firm services include imaging and therapy, customer resources and logins, healthcare financing solutions and laboratory diagnostics services. The company was founded in 1896 and is headquartered in Malvern, PA.

Altaris Capital Partners LLC (Altaris Capital Partners) is a private equity firm founded by George Aitken-Davies and Daniel Tully in 2003. The firm is headquartered in New York.

The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson.

The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012.

Galil Medical, Inc. develops, manufactures and markets cryotherapy systems and disposable products to treat prostate and renal cancer. Its treatment areas include conditions affecting bone, kidney, liver and lung, as well as targeted pain and nerve applications. The company was founded by Gideon Even Sturlesi in 1996 and is headquartered in Arden Hills, MN.

Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden.

Paramit Corp. engages n the provision of medical devices and life science instruments. It offers PCB assembly, vpoke mechanical assembly, optics capabilities, test solutions, and post manufacturing services. The company was founded by Billoo Rataul in 1990 and is headquartered in Morgan Hill, CA.

ChemImage Corp. produces hyperspectral imaging instrumentation and software for chemical and biological applications. It offers analytical, instrumentation and training services. The firm serves the biomedical, forensics, pharmaceutical and threat detection markets. The company was founded by Patrick Treado in 1994 and is headquartered in Pittsburgh, PA.

Sahlgrenska Universitetssjukhuset engages in the provision of basic and emergency medical care. It offers specialized care, pediatrics, transplant activity, treatment of cardiovascular diseases, immunology, and vaccine research. Its hospital provides an infrastructure necessary for teaching and research. The company was founded on January 1, 1997 and is based in Gothenburg, Sweden.

Part of XNK Therapeutics AB, CellProtect Nordic Pharmaceuticals AB is a clinical-stage biotechnology company based in Huddinge, SE. CellProtect Nordic Pharmaceuticals is one of the pioneering companies in the field of cell therapy, developing unique and individualized natural killer (NK) cell-based cancer therapies. The Swedish company has built a tailor-made GMP clean room facility for manufacturing clinical products and is currently evaluating its lead product, evencaleucel, in a randomized, controlled, phase II study for the treatment of multiple myeloma. The company was founded in 2012 and the CEO is Johan Liwing.

Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden.

The Children's Hospital of Philadelphia provides health care services. It specializes in pediatrics, research, fetal surgery, pediatric oncology, pediatric cardiology and cardiothoracic surgery, thoracic insufficiency syndrome, and pediatric airway disorders and transplants. The company was founded by Francis West Lewis in 1855 and is headquartered in Philadelphia, PA.

Xalud Therapeutics, Inc. develops novel therapies with several promising therapeutic programs for inflammatory. The firm offers XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. It also researches on the applicability of XT-101 for multiple sclerosis and amyotrophic lateral sclerosis. The company was founded by John Forsayeth and Linda Watkins and is headquartered in San Francisco, CA.

Part of Pfizer Inc., Pfizer Essential Health is an American company that manufactures pharmaceutical products.

Prokarium Ltd. operates as a biopharmaceutical company that focuses on developing vaccination solutions based on synthetic biology. Its oral vaccine delivery platform Vaxonella stimulates broad protective immune responses applicable to a wide range of diseases. The company is headquartered in Keele, the United Kingdom.

UK Research & Innovation is a partnership organization that works with universities, research organizations, businesses, charities, and government to create an environment that fosters research and innovation. The private company is based in London, UK. The organization aims to maximize the contribution of each component part, working both individually and collectively. UKRI collaborates with many partners to benefit everyone through knowledge, talent, and ideas.

Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA.

Amarna Therapeutics BV operates as a biotechnology company developing SVac viral gene delivery vector platform. The firm has developed a proprietary SuperVero cell line and SVec gene delivery platform for the development of safe and efficient immunotherapies for major indications within the degenerative, inflammatory and autoimmune disease areas. The company was founded by Ben van Leent and Peter de Haan in 2008 and is headquartered in Leiden, the Netherlands.

Synerkine Pharma BV focuses on developing novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain. The company was founded by Hans Preusting in 2018 and is headquartered in Utrecht, Netherlands.

Prokarium Holdings Ltd. provides management services. The private company is based in London, UK. The British company was founded in 2014. Kristen Albright has been the CEO of the company since 2018.

Part of Surmodics, Inc., Vetex Medical Ltd. is a medical company based in Galway, Ireland. The Irish company's first innovation is the Revene thrombectomy catheter, which is specifically engineered for the treatment of venous disease. The catheter is 510(k) cleared by the FDA for mechanical de-clotting and controlled and selective infusion of physician-specified fluids, including thrombolytics, in the peripheral vasculature. The company was founded by Mark Bruzzi, who has been the CEO since incorporation. Vetex Medical was acquired by SurModics MD LLC on July 06, 2021 for $59.78 million.

CairnSurgical, Inc. engages in provision of patient-specific tools to guide surgical interventions for patients with cancer. It offers personalized solution, improve care services, and MRI derived localization and guidance. The company was founded by Richard Barth Jr., Keith Paulsen, and Venkat Krishnaswamy and is headquartered in Lebanon, NH.

Tekiu Ltd. operates internet blogs that focus on trance and progressive house music. The British company was founded by Ted Ingemar Jakob Fjällman.

XNK Therapeutics AB operates as a technology platform which leads research on NK cells at Karolinska Institutet in Stockholm. The company was founded in 2012 and is headquartered in Huddinge, Sweden.

NorthX Biologics Matfors AB is a biologics company that specializes in high-quality protein production and DNA manufacturing. The company is based in Matfors, Sweden, and has subsidiaries in Sweden. The Swedish company offers comprehensive cell banking services, including master cell bank production, GMP cell banking, and cell bank characterization, ensuring quality and compliance for biological products. The company also provides premium plasmid DNA services, offering GMP, High Quality, and Research Grade plasmids for gene therapy, cell therapy, molecular biology research, and clinical applications. The company was founded in 1963, and Janet Hoogstraate has been the CEO of the company since 2023.

Alder Therapeutics AB is a cell therapy platform company that aims to develop and manufacture functional cell therapy products based on simple and robust processes. The company is based in Solna, Sweden. The Swedish company's unique platform allows for the manufacturing of better cells at a lower cost, making pluripotent cell therapy treatment available to more patients. The CEO of the company is Kristian Tryggvason.